FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The new online Learning Center with new content can still be found under the “Training” folder on ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...